Financial statement frauds are actions which are taken to intentionally distort a company's reported nancial performance. This manipulation is carried out with the help of accrual accounting. This is where Earnings management creeps in. Major corporate nancial shenanigans get away in the name of creative accounting. But, they need to be studied for lessons learned and strategies to avoid or reduce the incidence of such frauds in the future. It is essential for shareholders, particularly the common man who does not have any access to the company except reported nancial numbers. This research paper attempts to detect the nancial statement fraud in the Pharmaceutical Sector in India for investors' interest. Pharmaceutical Sector is one of the most upcoming sectors in India. It is more volatile for these aggressive accounting manipulations because of the keen competition and therefore it becomes imperative to make nancial users aware about them by the Indian corporate.
Thus, the present study tries to unleash the dimension of nancial Statement fraud in Indian pharmaceutical sector for shareholders in particular and society at large.
Literature review:
Financial statements fraud has always been an area of interest to the researchers worldwide. The earnings quality is measured by four separate earnings attributes: accruals quality, earnings persistence, earnings predictability, and earnings smoothness. We nd that the stressed/bankrupt rms prefer opportunistic earnings management; the nonstressed/non-bankrupt rms are more likely to choose more ef  c ient ea rnings ma na gement t ha n t he stressed/non-bankrupt rms. We nd that earnings management performs better than earnings quality in predicting future protability. We also nd that the earnings quality has deteriorated over the sample period; the number of stressed/bankrupt rms increased and the number of non-stressed/non-bankrupt rms decreased. 
Commerce
In the business environment, rms are expected to disclose accurate and reliable nancial information. Financial statement fraud is actions which are taken to intentionally distort a company's reported nancial performance. Major corporate nancial statement Frauds get away in the name of creative accounting. But, they need to be studied for lessons learned and strategies to avoid or reduce the incidence of such frauds in the future. It is essential for shareholders, particularly the common man who does not have any access to the company except reported nancial numbers. This research paper attempts to detect the practices of nancial statement fraud in the Pharmaceutical Sector in India for investors' interest using Earnings quality, De Angelo and Beneish models of fraud detection. The result conrms the presence of nancial statement fraud in the companies under study. It is therefore expected that the study will help to improves investor's belief of a company's performance, as reected in their nancial numbers.
operating efciency ratio analysis shows that the company recorded ctitious revenue amounting to RM 198,727. Therefore, these tools used in our investigation conrm that the company involve in manipulating their nancial statements.
Research methodology:
The study specically aims at the following objectives: Ÿ To test quality of earnings for indicative earnings manipulation for selected companies. Ÿ To detect the magnitude of discretionary accruals in regard to potential nancial statement fraud. Ÿ To nd out the manipulation score for the units under study as a part of nal verication of detected nancial statement fraud. Ÿ To highlight the major areas of concern in accounting manipulations in these undertakings for their future viability
Sample Size and Data Collection:
T h e p r e s e n t s t u d y c o v e r s t h e c o m p a n i e s i n t h e pharmaceutical sector of India. This study is based on the secondary data of 11 years from 2006 to 2016. The companies chosen as per the data availability are given below.
Tools/Techniques:
The following tools and techniques are used to identify fraudulent nancial statements:
Ÿ Quality of Earnings model: Quality of earnings is computed as the percentage of operating cash ow to net income of a rm. Higher the quality of earnings, lower the chances of earnings manipulation.
Ÿ The De Angelo Model:
The De Angelo Model is considered here for computing discretionary accruals. It is computed as follows:
Where:
DACit is discretionary accruals for rm i in period t; TAit and Ait -1 are Total Accruals and Total Assets for period t and t-l for rm I.
The above model has been used to determine the potential nancial statement fraud of the units under study.
Ÿ The Beneish M-Score Model:
The Beneish M-Score Model (Beneish Model), deployed as a nancial forensic tool, can assist in evaluating the probability of earnings manipulation in a company, as well as identifying areas that may require greater scrutiny. Beneish M-Score is a method that can be used to detect companies with a tendency to commit fraud on their nancial statements (Beneish, 2012) .
Empirically, companies with higher M-Score, have higher tendency to commit fraud.
If the M-score> -2.22, it shows indications of nancial fraud within companies.
The M score is based on a combination of the following eight different indices: 1. DSRI = Days' Sales in Receivables Index. This measures the ratio of days' sales in receivables versus prior year as an indicator of revenue ination. 2. GMI = Gross Margin Index. This is measured as the ratio of gross margin versus prior year. A rm with poorer prospects is more likely to manipulate earnings. 3. AQI = Asset Quality Index. Asset quality is measured as the ratio of non-current assets other than plant, property and equipment to total assets. AQI is the ratio of asset quality versus prior year. 4. SGI = Sales Growth Index. This measures the ratio of sales versus prior year. While sales growth is not itself a measure of manipulation growth companies are likely to nd them-selves under pressure to manipulate in order to keep up appearances.
DEPI = Depreciation
Index. This is measured as the ratio of the rate of depreciation versus prior year. A slower rate of depreciation (DEPI greater than 1) may means that the rm is revising useful asset life assumptions upwards, or adopting a new method that is income friendly.
SGAI = Sales, General and Administrative expenses
Index. This measures the ratio of SGA expenses to the prior year. This is used on the assumption that analysts would interpret a disproportionate increase in sales as a negative signal about rms future prospects 7. LVGI = Leverage Index. This measures the ratio of total debt to total assets versus prior year. It is intended to capture debt covenants incentives for earnings manipulation. 8. TATA -Total Accruals to Total Assets. This assesses the extent to which managers make discretionary accounting choices to alter earnings. Total accruals are calculated as the change in working capital accounts other than cash less depreciation.
These eight variables are then calculated together using the following formula: M = -4.84 + 0.92*DSRI + 0.528*GMI + 0.404*AQI + 0.892*SGI + 0.115*DEPI -0.172*SGAI + 4 . 6 7 9 * T A T A -.327*LVGI A score greater than -2.22 (i.e. less negative than this) signals a strong likelihood of a rm being a manipulator. An M-Score of less than -2.22 suggests the company will not be a manipulator. The analysis of the nancial statement require at least two period of nancial reporting to detect unusual event. However, to identify the trend of the company's nancial statement reporting, it is suggested to analyse the data for ve reporting period.
DATA ANALYSIS AND DISCUSSION:
The followings are the results of various analytical tools applied:
Ÿ Earnings Quality:
Following is the testing of quality of earnings of the sample companies under study. 
Interpretation:
Earnings Quality is said to be good for a company if it is above 100% and the ratio remains stable over the period and there is no wild uctuation in the value. The above Table-1 Indicates that only Torrent Pharma Ltd. has highest average earning quality above 100% indicating consistency in nancial performance but the performance is not promising. It is followed by dr. Reddy's ltd. has average 93.5% earnings quality ratio indicating that this company is making improvement in its nancial performance. There is high volatility in the earnings quality of Aurobindo Pharma Ltd and Piramal Enterprises Ltd. There is a huge uctuation in the quality of earnings among the selected companies. It indicates sheer inefciency and lack of clarity on part of the management of these companies.
Ÿ Discretionary Accruals (De-Angelo Model):
As Discretionar y Accruals is a proxy to earnings management, their trend indicates income-accrual management exercised by a company. If the trend in accruals is negative (positive), it indicates managers are making income-decreasing (increasing) accrual decisions, for example more(less) depreciation or decrease(increase) in inventory. Discretionary Accruals have been computed using the De-Angelo Model. 
Interpretation:
The table-3 shows the M-score of the selected companies. M-Score greater than -2.22, signals a strong likelihood of a rm being a manipulator. The evidence indicates that the probability of manipulation increase with: (1) Unusual increases in receivables, (2) Deteriorating gross margins, (3) Sales growth, (4) Increasing accruals.
Average M-Score of Cipla Ltd, Lupin Ltd, Cadila Healthcare Ltd, Divis Lab and Torrent pharma clearly indicate high likelihood of rm being manipulator which is matter of concern for their stakeholders. Average M-Score of Dr.Reddy and Aurobindo is nearer to -2.22 so it is also under consideration on account of probable manipulation. Sun Pharma, Biocon and Piramal have lowest average manipulation score indicating that they are not involved in manipulation practices.
Findings:
The 
CONCLUSION:
Ÿ Discretionary accruals act as a proxy to earnings manipulation. This study examines accrual management in the selected pharmaceutical companies in India. Ÿ Majority of the companies is having positive earnings quality indicating manipulation in their operating cash ow. Most of the units are found to be exercising incomeincreasing discretionary accruals, as veried by their positive average. Only Cipla Ltd, Sun Pharma Ltd and Torrent Pharma Ltd are exercising income-decreasing management on an average basis. So, manipulation in nancial statement is high for these three companies. The lack of transparency inherent in nancial reporting system implies that there is potential to misuse it as a powerful tool of earnings management by the management is high, e s p e c i a l l y w h e r e a n o rg a n i z a t i o n a l c h o i c e o f discretionary accruals to earnings management exists. Ÿ Beneish M-score model revealed that except Sun Pharma Ltd, Biocon Ltd and Piramal Enterprises Ltd, all other rms are manipulating nancial statements.
